Saphris 01
Saphris Tablet
Product Images NDC 0456-2402
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Saphris (NDC 0456-2402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Saphris 02
Saphris 03
This appears to be a technical document discussing the interaction of various substances with the enzyme CYP2D6. The substances listed include Paroxetine, Desipramine, and Acnapin, which may impact the effectiveness of Paroxetine. The document discusses PK, Cmax, and Auc values, and provides fold change data with 90% confidence intervals. Additionally, the text references a study measuring the impact of Saphiris on CYP2D6 enzyme levels. However, without more context, it is difficult to provide a more specific description.*
Saphris 04
This appears to be a table/chart detailing the population description and fold change for PK (pharmacokinetics) Cmax and Auc (area under the curve) with 90% C1 (confidence interval) for individuals with various medical conditions (renal and hepatic impairment), lifestyles (smokers), and ethnicity (Japanese). It also includes a mention that the data for pediatrics is different from adults, and that the results are based on a comparison of 3 subjects.*
Saphris 05
Saphris 06
Saphris 07
Saphris 08
Saphris 09
Saphris 0a
Saphris 0b
Saphris 0c
Saphris 0d
Saphris 0e
The text is a medication label for Saphris sublingual tablets containing Asenapine. The label gives instructions on how to use the tablet, dosage, storage, and the manufacturer details.*
Saphris 0f
Saphris 10
Saphris 11
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
